These studies suggest that although IL1β seems to have contrasting effects on the primary tumour, possibly dependent on the immune status of the mouse model used and the stage at which tumour cells are in when denied exposure to IL-1, low activity of IL-1/NFKB is consistently associated with significantly reduced metastasis, especially to the bone. This evidence concerns the gene IL1B and neoplasm.